By VC News Daily
BROOKLYN, NY, Matter Bio, a pioneering biotech company, announced the successful close of its seed round funding, raising $7 million.
Matter Bio, a pioneering biotech company dedicated to preserving genome integrity and extending healthy human lifespan, announced the successful close of its seed round funding, raising $7 million to advance its groundbreaking work in longevity research.
The seed round was led by Lifespan Vision Ventures, with participation from quadraScope Ventures and others, and includes grant support from NIH, NCI, and NIEHS. The
(c) by Massinvestor, Inc. For contact info, please check out our about page.